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Background. The heart forms from a linear tube that is subject to complex remodeling during embryonic development.
Hallmarks of this remodeling are the looping of the heart tube and the regionalization into chamber and non-chamber
myocardium. Cardiomyocytes in the future chamber myocardium acquire different cellular and physiological characteristics
through activation of a chamber-specific genetic program, which is in part mediated by T-box genes. Methodology/Principal
Finding. We characterize two new zebrafish T-box transcription factors, tbx3b and tbx2a, and analyze their role during the
development of the atrioventricular canal. Loss- and gain-of-function analyses demonstrate that tbx3b and tbx2a are necessary
to repress the chamber-genetic program in the non-chamber myocardium. We also show that tbx3b and tbx2a are required to
control cell proliferation in the atrioventricular canal and that misregulation of cell proliferation in the heart tube influences
looping. Furthermore, we characterize the heart phenotype of a novel Tbx3 mutation in mice and show that both the control of
cell proliferation and the repression of chamber-specific genetic program in the non-chamber myocardium are conserved roles
of Tbx3 in this species. Conclusions/Significance. Taken together, our results uncover an evolutionarily conserved role of
Tbx2/3 transcription factors during remodeling of the heart myocardium and highlight the importance of controlling cell
proliferation as a driving force of morphogenesis.
Citation: Ribeiro I, Kawakami Y, Bu ¨scher D, Raya A ´, Rodrı ´guez-Leo ´n J, et al (2007) Tbx2 and Tbx3 Regulate the Dynamics of Cell Proliferation during
Heart Remodeling. PLoS ONE 2(4): e398. doi:10.1371/journal.pone.0000398
INTRODUCTION
The T-box (Tbx) family of transcription factors is represented in all
metazoans [1] and is characterized by a highly conserved DNA
binding domain, the T-box domain. Several Tbx genes are
expressed during embryonic development in specific domains and
have been implicated in the formation of a variety of organs,
including the heart. The existence of several human congenital
syndromes caused by disruption of human TBX genes, demonstrates
their importance in morphogenesis. The Holt-Oram syndrome is
causedbyTBX5haploinsufficiencyandischaracterizedbyheartand
hand anomalies [2]. Mutations in TBX1 have been implicated in the
Velocardiofacial or DiGeorge syndrome in which congenital heart
defects are present [3]. Several Tbx genes are expressed in the heart
in discrete and overlapping regions and have been shown to be
important for the development of such complex organ.
The embryonic linear heart tube undergoes complex remodel-
ing, including looping and regionalization, to form the final
vertebrate multichambered heart. Initially, the primary myocar-
dium is morphologically homogenous throughout the extent of the
linear heart tube. Concomitantly with the beginning of looping,
the heart tube becomes regionalized into chamber myocardium,
the atria and the ventricles, and non-chamber myocardium, the
outflow tract (OFT), the atrioventricular canal (AVC), the inflow
tract (IFT) and the inner curvatures. The chamber myocardium
becomes fast conducting myocardium whereas the non-chamber
myocardium retains slow conduction, thereby participating in the
establishment of synchronized beating in the embryonic heart [4].
Additionally, the myocardium of the future chambers starts to
grow out of the primitive heart tube during looping. Consequently,
the non-chamber myocardium forms constrictions in the heart
tube, such as the AVC, that prevent backflow of blood before valve
formation. A variety of chamber and non-chamber specific genes
have been characterized. The expression of chamber markers,
such as atrium natriuretic factor (Anf), connexin 40 and 43 (Cx40,
Cx43), Chisel and bone morphogenetic protein 10 (Bmp10), comes
on concomitantly with the start of chamber growth in the mouse
heart tube [5,6]. The myocardium fated to become non-chamber
myocardium expresses a different set of molecular markers. Bmp2
and Tgfb2 are expressed in the OFT, AVC and IFT since early
loopingstages andareimportant forfurtherdevelopment ofthe non-
chamber myocardium [7,8]. Thus, differentiation of the primary
myocardium and looping are the first steps of heart remodeling.
Tbx5 plays a role during chamber formation despite being
expressed throughout the extent of the heart tube. It has been shown
that Tbx5 synergistically interacts with Nkx2.5 in the activation of
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cardiac chambers [9]. A similar regulatory element, composed of
TBE and NKE binding sites, has been found in the promoters of
other chamber-specific genes, such as Cx40 and Cx43 [10]. The lack
of expression of chamber specific genes in non-chamber myocardi-
um has been attributed to the expression of Tbx2 which is mutually
exclusive with that of chamber myocardium markers [11]. Tbx2
cooperates with Nkx2.5 and represses transcription from ANF
regulatory element, serving as inhibitors of the chamber-specific
genetic program. Supporting this model, misexpression of Tbx2
under the control of b-MHC promoter results in the lack of chamber
growth and downregulation of Anf, Chisel and Cx40 [12]. However,
mice with targeted mutations in Anf, Chisel or Cx40 have normal
heart development and reach adulthood [13–16], suggesting that the
absence of their expression in b-MHC::Tbx2 mice does not account
for the lack of chamber growth. Recently, it has been shown that
Tbx2 represses transcription of the cell cycle gene Nmyc1.T h e
ectopic expression of Tbx2 throughout the heart tube has been
suggested to cause the hypoplastic phenotype observed in Tbx20
mutants [17–19]. The chamber-specific genetic program is not
initiated in Tbx20 mutants, suggesting that downregulation of Tbx2
in the chamber myocardium is crucial for normal heart de-
velopment. Although Nmyc1 mutant hearts are hypoplastic [20,21],
the cardiac chambers are formed and the overall phenotype is much
less severe than that of Tbx20 mutant or b-MHC::Tbx2 hearts,
suggesting that regulation of additional downstream targets of Tbx2
may be involved in chamber and non-chamber myocardium
differentiation. Moreover, ablation of Tbx2 causes defects in the
AVC and a failure in OFT septation in only a quarter of the
homozygous embryos [22], indicating that other factors are able to
compensate for the lack of Tbx2.
Tbx3 is co-expressed with Tbx2 in the heart in looping stages and
biochemical studies suggest Tbx3, like Tbx2, is capable of repressing
transcription from the ANF element in chamber specific genes [10].
In humans, haploinsufficiency of TBX3 causes the Ulnar Mammary
syndrome (UMS), a pleiotropic disorder that typically presents
defects in limb, mammary gland, tooth, hair and apocrine gland
development [23]. This autosomal dominant disorder is fully
penetrant, however there is a large variability in the clinical
presentation among affected individuals and cardiac anomalies have
recently been reported [24,25]. Micelacking Tbx3 are not viable and
display a wide range of onset of lethality, between E10.5 and E16.5,
which correlates with the variability of clinical presentation in UMS
patients[26].AlthoughTbx3isexpressed inrestricted domainsinthe
mouse and human hearts from early stages [10], heart formation has
not been specifically addressed in Tbx3 mutant embryos.
The processes of heart looping and chamber formation are less
well studied in other vertebrates. In zebrafish, it is known that the
initial broad expression of bmp4 and versican become restricted to
the myocardium at the level of the AVC during initiation of
looping [27,28]. As for chamber markers, zebrafish anf is expressed
in chamber myocardium after looping is well under way [29].
However, the mechanism whereby heart remodeling occurs in
zebrafish remains to be elucidated.
The simplicity and accessibility of the two-chambered heart in
zebrafish allow a deeper analysis of the complex morphogenetic
events involved in heart development. In this report, we show that
novel Tbx2 and Tbx3 zebrafish homologs prevent initiation of the
chamber-specific genetic program and growth in non-chamber
myocardium. We also analyze cardiac defects in mice Tbx3 mutant
embryos and show that Tbx3 plays a role in heart remodeling.
Together our findings reveal the importance of a tight equilibrium
between cell proliferation and differentiation in order to achieve
proper organogenesis.
RESULTS
Zebrafish tbx3b and tbx2a are required for heart
looping and AVC formation
We isolated two novel Tbx genes in zebrafish, which belong to the
Tbx2 subfamily. Based on sequence similarity and expression
patterns we named them tbx3b and tbx2a (Fig. S1). tbx3b encodes
a putative protein of 694 amino acid residues with overall
similarity to human TBX3 of 67.8% and to mouse Tbx3 protein of
67.3%. tbx2a encodes a putative protein of 687 amino acid residues
with 61.8% similarity to mouse Tbx2, 63.1% to human TBX2 and
78.2% to zebrafish tbx2b. During heart development, tbx3b is first
expressed throughout the extent of the heart tube and becomes
restricted to the AVC and OFT at 33 hpf (Fig. 1A,B). Zebrafish
tbx2a is first weakly expressed throughout the extent of the heart
tube becoming later restricted to the AVC (Fig. 1C,D). Thus, the
domain of expression of tbx3b and tbx2a in the heart is similar to
that of the mouse counterparts [10,22].
The expression pattern of tbx3b and tbx2a suggested that they
might play a role in heart regionalization in zebrafish. Morpholino
oligonucleotides (MO) were used to knock down tbx3b and tbx2a in
a transgenic line expressing GFP in the heart, mlc2a::GFP [30].
The efficacy of the MOs to inhibit translation of tbx3b and tbx2a
mRNA were confirmed by co-injecting tbx3b:EGFP or tbx2a:EGFP
fusion constructs and examining fluorescent signal (Fig. S2).
Injection of tbx3b MO resulted in a growth delay from 36 hpf
onwards, absence or reduction of fin buds and misformation of the
otic vesicle and lethality past 3 dpf (I.R. and J.C.I.B., unpublished
observations). In control embryos at 48 hpf the AVC was a tight
constriction between the ventricle and the atrium and these two
chambers were at the same anterior-posterior level (Fig. 1E). In
stage-matched tbx3b morphant embryos, the atrium-ventricle
border was wide and looping was delayed (Fig. 1F). By 3 dpf,
the pericardiac cavity was severely swollen, looping was in-
complete and the presumptive AVC remained wide (Fig. 1J). Loss
of function of tbx2a resulted in similar heart defects, with
incomplete looping and lack of AVC constriction (Fig. 1G,L).
However, in contrast to tbx3b morphants, the fin buds and the otic
placodes developed normally in tbx2a morphants and there was no
growth delay (I.R. and J.C.I.B., unpublished observations),
suggesting that these genes play specific and non-overlapping
roles in the development of other organs. Upon co-injection of
both tbx3 and tbx2a MOs we observed that fin bud was absent and
the otic placode was reduced (Fig. S2). In the heart of double
morphants, the AVC failed to form, and there was no indication of
looping (Fig. 1H,M). Although development of other organs was
not more affected in double morphants than in tbx3b MO-injected
embryos, the heart phenotype was more severe when both tbx3b
and tbx2a were knocked down, implying that tbx3b and tbx2a play
non-redundant roles in cardiac development.
To test if the absence of the AVC constriction and looping were
convoyed by defects in the heart regionalization, we assessed the
expression of AVC markers in zebrafish. The expression domains
of bmp4 and bmp2b in OFT, AVC and IFT of the heart were not
altered in single and double morphant embryos (Fig. 2A–D, data
not shown). The expression domain of notch1b, which normally
becomes restricted to the endocardium at the level of the AVC and
OFT at 45 hpf [31], was expanded into the ventricle endocardium
of tbx3b and tbx2a morphant embryos at 48 hpf (Fig. 2E,F,G), as
well as in stage-matched double morphant embryos (Fig. 2H).
Zebrafish anf is first expressed throughout the primitive heart tube
and later becomes expressed exclusively in the chambers (our
unpublished observations) [29]. In tbx3b, tbx2a, and double
morphants, however, anf transcripts continued to be expressed
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not shown). Zebrafish bmp10 is expressed in the heart in a dynamic
pattern reminiscent of zebrafish anf as well as in the otic vesicle and
ventricle of the brain (Fig. S3). In tbx3b and tbx2a morphant
embryos, bmp10 was downregulated from the AVC as in control
embryos (Fig. 2I–L). However, in double morphants bmp10 was
present throughout the extent of the heart tube (Fig. 2M).
Together these results show that the initial specification of
chamber and non-chamber myocardium occurs in single and
double morphants, but further development is impaired.
Ectopic presence of Tbx3 and Tbx2 results in the
absence of chamber growth
We next asked if the ectopic expression of Tbx3 and Tbx2 in
chamber myocardium was able to prevent chamber formation.
Tbx3-injected embryos developed at comparable rates as the
GFP-injected embryos. At 60 hpf, 44.5% of the embryos over-
expressing Tbx3 presented a swollen pericardiac cavity and a delay
in heart looping. Most notably, however, was the lack of chamber
growth, which, added to the increasing pericardial swelling due to
low circulation, gave rise to a thin heart tube that stretched from
the base of the head to the yolk (Fig. 3B; compare to 3A),
a condition previously described as pipe-like heart [27]. In 60%
Tbx2-injected embryos the pericardiac cavity was swollen from
48 hpf onwards (Fig. 3C). A similar pipe-like heart phenotype was
Figure 2. in situ hybridization analysis of cardiogenesis in the
absence of tbx3b and tbx2a. Ventral views of the heart in its maximum
extension from the anterior to the posterior pole. (A) bmp4 is expressed
in the non-chamber myocardium of the heart, the OFT, the AVC and the
IFT. (B, C, D) The expression pattern of bmp4 is normal in 42 hpf tbx3b,
tbx2a and double morphants. (E) notch1b is expressed in the whole
endocardium of the heart tube, but becomes restricted to the
endocardium at the level of the OFT and AVC upon looping. (F, G, H)
Expression of notch1b is maintained in the endocardium at the level of
the chamber myocardium in 48 hpf tbx3b, tbx2a and double
morphants, in contrast to wild type. (I) bmp10 is expressed exclusively
in chamber myocardium at 42 hpf (J, L, M) In 42 hpf tbx3b and tbx2a
morphants bmp10 is expressed in the chamber myocardium and is
downregulated in the AVC, as is the case in wild type, but it is not
downregulated from the AVC in double morphants. Red arrow indicates
the AVC. a, atrium; h, heart; v, ventricle.
doi:10.1371/journal.pone.0000398.g002
Figure 1. Aberrant morphology of the AVC in the absence of
zebrafish tbx3b and tbx2a. (A–D) Whole mount RNA in situ
hybridization of zebrafish tbx3b and tbx2a expression; ventral views
show the heart in its maximum extension from the anterior to the
posterior pole. Zebrafish tbx3b is expressed throughout the extent of
the heart tube at 31 hpf (A) and becomes restricted to the AVC at
42 hpf (B). Zebrafish tbx2a is expressed al low levels throughout the
extent of the linear heart tube at 31 hpf (C). At 42 hpf tbx2a transcripts
are present in the AVC at high levels (D). Black arrow points to the AVC.
(E–M) Ventral views of the heart of a mlc2a::GFP transgenic line that
expresses GFP in the myocardium, at 48 hpf (E–H) and 72 hpf (I–M). (E)
In wild type 48 hpf embryos, the atrium has moved upward and is
positioned at the same anterior-posterior level as the ventricle; (I) later
the atrium becomes localized dorsal to the ventricle at 72 hpf. (F, J)
Injection of 2.5 ng of tbx3b morpholino into one-cell stage embryos
results in delayed heart looping and abnormal AVC. (G, L) Injection of
10 ng of tbx2a MO results in a similar delay in heart looping and an
enlargement of the AVC. (H, M) Injection of both tbx3b and tbx2a MOs,
at 1.75 and 5 ng respectively, results in the failure to form the AVC
constriction and absence of looping. Red arrow indicates the AVC. a,
atrium; h, heart; v, ventricle.
doi:10.1371/journal.pone.0000398.g001
Figure 3. Heart morphology in embryos overexpressing Tbx3 and
Tbx2. Side views (A–C) and ventral views (D–F) of wild type embryos (A,
D) and embryos injected with 100 pg capped mRNA for mouse Tbx3 (B,
E) or human TBX2 (C, F). (A, B, C) mlc2a::GFP embryos at 60 hpf; (D, E, F)
48 hpf. (B, C) 44.5% of Tbx3-injected embryos and 60% of Tbx2-injected
embryos present a pipe-like heart that lacks chamber growth and
looping. (D, E, F) Zebrafish bmp10 is strongly expressed in the chamber
myocardium in wild type embryos, but is significantly downregulated
from the heart in Tbx3- or Tbx2-injected embryos. a, atrium; v, ventricle.
doi:10.1371/journal.pone.0000398.g003
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bmp10 was significantly downregulated in the heart in Tbx3- and
Tbx2-injected embryos (Fig. 3D,E,F). Transcripts of anf were not
downregulated from the AVC of Tbx3- and Tbx2-overexpressing
hearts at 48 hpf and presented levels of expression similar to the
wild type 24 hpf heart (data not shown). The overexpression of
Tbx3 or Tbx2 did not affect the expression of notch1b or bmp4 (data
not shown). Thus, the specification and differentiation of non-
chamber myocardium is not altered in the presence of ectopic
Tbx3 or Tbx2 in the heart tube. However, the presumptive
chambers do not grow from the primitive heart tube, and maintain
levels of expression of chamber markers characteristic of primary
myocardium.
tbx3b and tbx2a are required to establish the
pattern of proliferation during heart looping
The absence of chamber growth in Tbx3- and Tbx2-injected
embryos prompted us to investigate the cell division and apoptosis
levels during heart looping. In wild type embryos between 31 and
48 hpf, no significant numbers of apoptotic cells, as evaluated by
acridine orange staining, were observed in the heart (data not
shown). Additionally, no differences were observed between Tbx3-
or Tbx2-injected and wild type embryos in the number of
apoptotic cells in the heart tube (data not shown). To study the
pattern of proliferation in the looping heart we gave a one-hour
pulse of BrdU by injecting a BrdU solution in the pericardiac
cavity. In 31 hpf wild type embryos the heart presented no signs of
looping and chamber formation. The BrdU-positive cells were
equally distributed throughout the extent of the heart tube
(Fig. 4A). At 33 hpf, the anterior region of the heart tube, the
future ventricle, has jogged to the right, allowing a rough
distinction between the two future chambers and the future
AVC. At this stage, the BrdU positive cells were more con-
centrated in the future chamber regions, leaving the AVC region
devoid of BrdU-positive cells (Fig. 4B). At 36 hpf the initial phase
of heart looping is already completed and it is possible to clearly
identify the ventricle and the atrium, as well as the OFT and the
AVC. Thus, a dynamic pattern of cell proliferation along the heart
tube accompanies chamber outgrowth, and a crucial differentia-
tion step occurs at 33 hpf, concomitant with the rightward jogging
of the future ventricle.
The pre-looping heart tube of Tbx3-injected embryos appears
normal in size and morphology (data not shown). However, at
33 hpf there were no signs of looping and the dividing cells were
homogenously distributed throughout the heart tube, with no
obvious separation between ventricle and atrium (Fig. 4C).
Moreover, the total number of BrdU-positive cells in the heart
was significantly lower when compared to wild type embryos
(Fig. 4H). Similar altered numbers and distribution of BrdU-
positive cells were observed in the hearts in Tbx2-injected embryos
at 33 hpf (Fig. 4D,H). These results indicate that the lack of
chamber outgrowth in the presence of ectopic Tbx3 and Tbx2 is
due to a decrease in the cell proliferation levels in the future
chamber myocardium. In 33 hpf stage-matched tbx3b or tbx2a
morphants, the distribution of dividing cells was not regionalized
as in control hearts (Fig. 4E,F,G). The 33 hpf heart tube of double
morphant embryos displayed an homogenous distribution of
BrdU-positive cells and the total number of dividing cells was
slightly higher than in wild type (Fig. 4H). Differences in the
number of BrdU-positive cells in the AVC myocardium may be
difficult to detect due to the small number of cells in this region.
Together these results demonstrate that tbx3b and tbx2a are crucial
for the establishment of the dynamic pattern of cell proliferation in
the heart tube and further show that perturbation of this pattern
may have drastic consequences for heart looping.
Ablation of Tbx3 in mice causes cardiovascular
defects
In order to investigate if the role of Tbx3 in zebrafish heart
morphogenesis is conserved in mammals, we analyzed the
cardiovascular development in mice embryos lacking Tbx3
function. Mice with a targeted mutation for Tbx3 were generated
(Materials and Methods, Fig. S4). Homozygous Tbx3 null embryos
presented poorly developed yolk sac vasculature, truncated
hindlimbs and were smaller than their littermates, similar to what
has been described for another Tbx3 mutant [26].
In Tbx3 mutant embryos, we observed a large phenotypic
variability in the time of onset and degree of the heart defects. In
4/40 homozygous embryos collected 9.5 days post coitum (E9.5),
a delay in heart looping was evident (Fig. 5A,B). In 33% of the
Tbx3 mutant embryos collected at E10.5 (n=21), the pericardiac
cavity was swollen and the heart incompletely looped (Fig. 5C,D).
The defects in looping ranged from a mild delay to a completely
unbent tube (Fig. 5D). The constriction at the AVC was also
enlarged when compared to wild type or heterozygous littermates.
At later stages, all Tbx3 mutant embryos were readily distinguish-
able from their littermates in that they were smaller and presented
a reduced hindlimb bud (our unpublished observations). 43% Tbx3
mutant embryos recovered at E11.5 (n=7) presented a swollen
pericardial cavity with an unlooped heart (Fig. 5E,F). These
observations suggest that there is a great phenotypic variation in
the severity of the cardiovascular defects in Tbx3 mutant embryos.
Nevertheless, the most severe mutants display cardiac anomalies
comparable to the heart defects seen in tbx3b morphant embryos.
To test if the AVC is correctly specified in Tbx3-mutant embryos,
we analyzed the expression pattern of Bmp2, which is expressed in
the AVC and is crucial for the formation of atrioventricular valves in
the mouse [8]. Bmp2 transcripts were present in the AVC of Tbx3
mutant embryos at E9.5 (Fig. 5I,J), suggesting that this non-chamber
region is properly specified. To test if further development of the
AVC wasoccurringnormally, we analyzed TGFb2 and Smad6 which
are expressed in the OFT and the AVC at the level of the
myocardium and endocardium, respectively, and are required for
cushion mesenchyme formation [32,33]. In Tbx3 null mutant
embryos, both TGFb2 and Smad6 were downregulated in the non-
chamber myocardium (Fig. 5L–O). Expression of Msx2, another
marker of AVC myocardium, was downregulated in Tbx3 mutant
embryosatE9.5 (datanotshown).Thus,theearlyspecificationofthe
AVCseemsto occurnormally,howeverfurtherdifferentiation ofthis
myocardium is perturbed in Tbx3 null mutants.
Next we analyzed the expression of chamber myocardium
markers, Anf and Bmp10. In the most severe class of Tbx3-null
mutants, Anf was upregulated in the region between the ventricle
and the atrium (data not shown). Bmp10 is normally expressed in
the chambers at E9.5 marking the future trabeculating myocar-
dium [6]. In Tbx3-null homozygous embryos Bmp10 transcripts
were found ectopically in the OFT and the AVC at E9.5
(Fig. 5G,H), suggesting that in the absence of Tbx3, Bmp10 is
activated in non-chamber myocardium. We found NKE- and
TBE-sites in the promoter region of human BMP10 (Fig. 5P),
which suggest that Bmp10 is subject to similar transcriptional
regulation as Anf and Cx40 [4]. Tbx5 is required for chamber
formation [34] and was normally expressed in Tbx3 mutant
embryos (data not shown). The analysis of the expression patterns
of chamber and non-chamber markers in Tbx3 mutant embryos
advocates that the initial specification of non-chamber myocardi-
Tbx Genes in Heart Development
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development of the AVC is not achieved and instead, chamber
markers are upregulated. Moreover, the most severe class of Tbx3-
null mutant embryos displays heart defects that are similar to
zebrafish tbx3b morphants with respect to morphology and the
degree of development, indicating that the mechanisms of AVC
formation are conserved among vertebrates.
Previous studies show that the sinoatrial region, the AVC and, to
a lesser extent, the OFT present lower levels of cell proliferation
compared to the chamber myocardium [35,36]. Since the AVC
constriction is unusually wide in Tbx3-null mutants and there is
ectopic activation of the chamber genetic program, we analyzed
whether the pattern ofcellproliferation was altered inthese mutants.
Consistent with previous findings [35], wild type E9.5 embryos
Figure 4. The pattern of proliferation along the heart tube is dynamic and is regulated by Tbx3 and Tbx2. All images represent reconstructions of
confocal Z-stack sections imaged on whole embryos at 31hpf (A) and 33 hpf (B–G). (A, B) During the first steps of looping, the pattern of proliferation
shifts from homogenous throughout the heart tube (31 hpf, A) to a heterogenous one in which dividing cells are more concentrated in the future
chambers (33 hpf, B). (C, D) In Tbx3- (C) and Tbx2- (D) injected embryos at 33 hpf this shift has not occurred and the number of dividing cells was
significantly decreased and dividing cells were homogenously distributed (H). (E–G) MO-injected embryos against tbx3b (E), tbx2a (F) or both (G)
display the same (E, F) or higher (G) number of proliferating cells than wild type at 33 hpf. However, proliferating cells remain homogenously
distributed throughout the heart tube. (H) Histogram showing the average of the total number of BrdU positive cells in the heart of 33 hpf embryos:
wt, 31.461.661 (n=5); Tbx3 mRNA, 17.561.708 (p,0.001; n=6); Tbx2 mRNA, 17.061.000 (p,0.001; n=7); tbx3b MO, 28.060.408 (n=4); tbx2a MO,
31.362.658 (n=4); double MO, 36.861.797 (n=4). a, atrium; h, heart; nt, neural tube; v, ventricle.
doi:10.1371/journal.pone.0000398.g004
Tbx Genes in Heart Development
PLoS ONE | www.plosone.org 5 April 2007 | Issue 4 | e398labeled with a one-hour pulse of BrdU present a lower density of
BrdU-positive cells in the OFT and the AVC when compared to the
ventricle or the common atrium (Fig. 6A, data not shown). Tbx3
mutant embryos subjected to the same treatment displayed densities
of proliferating cells in the OFT similar to wild type embryos.
However, the density of proliferating cells at the level of the AVC
myocardium was comparable to that of the ventricle myocardium,
ratherthanto that ofthewild type AVCmyocardium (Fig.6A,Band
data not shown). In addition to the analysis of BrdU-labeled cells, we
also examined the pattern of mitotic cells in the looping heart by
detection of phospho-Histone3-positive cells. Exhaustive counting of
the phospho-Histone3-positive cells in each section revealed that
proliferation levels were not altered in the OFT, the ventricles or the
common atrium at E9.5 in Tbx3 mutant embryos (n=2/3) relative
to wild type counterparts (n=3/4; data not shown). In spite of this,
the number of dividing cells was significantly increased in the AVC
of Tbx3 mutant embryos (n=3/3) when compared to wild type
embryos (4/4; Fig. 6C). These results suggest that Tbx3 is an
important regulator of the rate of proliferation in the AVC and
reveal that the role of Tbx3 is conserved in zebrafish and mouse
heart development.
DISCUSSION
In this report, we have studied the role of two novel zebrafish
genes, tbx3b and tbx2a, in the process of heart remodeling and the
associated differential cell proliferation. Incomplete looping was
observed both after gain- and loss-of-function experiments. The
pattern of cell proliferation along the heart tube was perturbed in
either case, suggesting that differential rates of cell proliferation are
important for proper looping to occur. In the absence of tbx3b and
tbx2a, the broadening of the AVC constriction may hamper heart
tube bending by abolishing the flexion point. On the other hand,
the chamber growth out of the primary heart tube may be
a permissive factor for the bending of the heart tube along with
other intrinsic and extrinsic biomechanical driving forces [37], as
evidenced by the absence of looping in the gain-of-function
experiments. Supporting this hypothesis, heartstrings mutant and
hrT morphants display an absence of chamber formation and
impaired heart looping [27,38]. Perturbation of heart looping in
fog1 morphants does not correlate with lack of chamber growth
[39], suggesting that chamber growth is not sufficient for proper
looping to occur. In mice, lack of Tbx5 and Nkx2.5 results in an
hypoplastic heart and absence of looping [11,34], indicating that
lack of looping in the absence of chamber growth is conserved in
mice. Tbx3 and Tbx2 may also be involved in other aspects of the
process of heart looping not related to chamber growth. It has
been previously shown that Tbx genes can regulate extracellular
matrix composition and cell adhesion [40], which are important
factors in the bending of the heart tube [41].
Frequently during embryonic development, two adjacent tissues
present disparate rates of cell division and the maintenance of
these discrepancies is important for proper morphogenesis to
occur. In the heart, the rate of cell proliferation is higher in
chamber myocardium compared to the non-chamber myocardi-
um in mouse [35,36] and there is a correlation between absence of
chamber formation and lower levels of cell proliferation [42,43].
Analysis of the pattern of cell proliferation along the extent of the
zebrafish heart tube revealed that cell proliferation is dynamic
throughout heart development, increasing upon initiation of
chamber formation (this study). We show that tbx3b and tbx2a
are necessary to break the uniform distribution of dividing cells in
the zebrafish heart by repressing cell proliferation. T-box
transcription factors have been previously implicated in the
control of cell proliferation in several developmental contexts
[19,44,45] and in one case, this control has been shown to be
direct: Tbx2 downregulates expression of Nmyc1 in the context of
heart development [43]. Thus, one possible mechanism for cell
proliferation control in the non-chamber myocardium by tbx2a
and tbx3b is by regulation of expression of cell cycle genes.
Concomitant with differential increase in cell proliferation in the
heart tube is the activation of a chamber-specific genetic program
in chamber myocardium. tbx2a and tbx3b repress the transcrip-
tion of bmp10 in the AVC. Mouse Bmp10 has been shown to be
required for chamber growth and maturation [42], indicating that
Bmp10 is a chamber-specific gene that is actually required for
chamber growth and maturation. In Bmp10-null hearts, the cell
cycle inhibitor p57 (kip2) is upregulated and the rate of cell
proliferation is lower than in wild type hearts [42]. The presence of
putative NKE- and TBE-binding sites in tandem in upstream
sequences of human BMP10 suggest that regulation of this
chamber marker could be similar to the that of Anf, Cx40 and
Cx43 [4]. Thus, regulation of chamber versus non-chamber
genetic programs may be achieved by Bmp10, which we show is
altered in the absence of tbx2a and tbx3b in zebrafish and Tbx3 in
mouse.
Figure 5. Mice with a targeted mutation for Tbx3, Tbx3
neo display
cardiac defects. (A, B) Severely affected Tbx3 mutant embryos (B)
present a delay in heart looping at E9.5, in which the ventricle is still at
the same dorsoventral position as the atrium. (C, D) At E10.5, the most
affected Tbx3 mutant embryos display obvious heart defects, including
lack of the constriction in the AVC and absence of looping in a swollen
pericardiac cavity (D), compared to wild type (C). (E, F) E11.5 Tbx3 null
homozygous embryos present a significant delay in heart looping and
pericardiac swelling compared to wild type. (G–O) Whole mount in situ
hybridization analysis at E9.5; ventral views (G, H) and lateral views (I–O).
(G, H) Upon looping initiation, Bmp10 starts to be expressed in the
chamber myocardium. However, Bmp10 was ectopically expressed in
the non-chamber myocardium of the heart of Tbx3 mutant embryos
(arrow in G, H). (I, J) Bmp2 is expressed in the AVC myocardium at E9.5
and was not altered in Tbx3 mutant embryos. (L, M) TGFb2 is normally
expressed in the non-chamber myocardium of the looping heart. In
Tbx3 mutant embryos, expression of TGFb2 is downregulated in the
heart. (N, O) Smad6 is expressed in the endocardium at the level of the
OFT and AVC at E9,5. However, in Tbx3 mutant embryos, expression of
Smad6 is absent. (P) Consecutive NKE and TBE binding sites are found in
the human BMP10 promoter, between 9800 and 10100 bp upstream
the ATG codon. a, atrium; lv, left ventricle; o, outflow tract; pc,
pericardiac cavity; rv, right ventricle; sa, sinoatrial region.
doi:10.1371/journal.pone.0000398.g005
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observed upon ablation of Tbx3 in the mouse. It has been
suggested that defects in cardiac looping are at the origin of
cardiac defects of TGFb2 mutant embryos, which display an
overriding tricuspid valve and double outlet right ventricle [7].
Furthermore, TGFb2 can trigger cell cycle arrest by induction of
p21 expression in other contexts [46]. In the converse experiment,
cardiac-restricted expression of a constitutively active form of the
type I TGFb receptor Alk5 results in defective heart looping,
hypocellularity and upregulation of p21 [47]. These studies suggest
that TGFb2 must play role in heart remodeling and TGFb2
downregulation in Tbx3-null hearts may explain the increase in
cell proliferation and defect in heart looping observed.
Loss-of-functionoftbx2aandtbx3beachindependentlyresultedin
malformation of AVC constriction due to altered cell proliferation
rates and incomplete looping. Ablation of Tbx2 or Tbx3 indepen-
dently in mouse also result in AVC malformation [22] and, in the
case of Tbx3, in incomplete looping and altered cell proliferation rates
in the AVC. These observations imply that the roles of Tbx2 and
Tbx3 are conserved in both vertebrates. Upon knock down of both
tbx2aand tbx3b we observed absence of AVC constriction and looping
altogether and the defects in cell proliferation were more severe,
suggesting that tbx2a and tbx3b play additive roles in heart
morphogenesis. As repressors of transcription, tbx2 and tbx3 may
simply have different transcriptional targets in the nucleus. Low
similarity of protein sequences outside the T-box domain [48] may
signify association with different cofactors, supporting this hypothesis.
The identification of transcriptional targets and binding partners of
Tbx2 and Tbx3 would clarify this issue.
Cardiac looping involves a complex set of movements of
discrete regions of the heart tube that are correlated with the
regionalization of the heart, i.e., the appearance of molecular and
cellular characteristics specific for each heart region. A differential
rate of cell proliferation along the heart tube results in growth of
cardiac chambers out of the primary myocardium thereby creating
the AVC constriction. Tbx2 and Tbx3 repress the induction of
chamber-specific genes and cell proliferation in the AVC. The
AVC constriction may act as a flexion point that facilitates the
bending of the heart tube. On the other hand, defects in cardiac
looping are at the origin of malformations in the valve s due to
Figure 6. The pattern of proliferation in the E9.5 heart tube is altered in Tbx3 mutant hearts. Immunohistochemical analysis of cell proliferation in
E9.5 wild type (A) and Tbx3 mutant (B) hearts using antibodies against BrdU (A, B) or phospho-Histone 3 (C). (A, B) Representative sections at the level
of the AVC of wild type and mutant hearts are shown. The heart is outlined by a discontinuous white line. The density of BrdU positive cells is higher
in the AVC of mutant hearts than in the AVC of wild type hearts (red arrowheads). (C) The number of phospho-Histone3-positive cells in the AVC was
counted in consecutive heart sections at the level of the AVC of four wild type embryos with 30–31 somites and three mutant embryos with 30–32
somites. The average number of mitotic cells for the AVC is represented in a histogram. The number of mitotic cells in the AVC is significantly
increased (P,0.010) in mutant embryos (90.7612.7), compared to wild type embryos (58.3614.5). A, atrium; AVC, atrioventricular canal; OFT, outflow
tract; V, ventricle.
doi:10.1371/journal.pone.0000398.g006
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looping and regionalization are deeply interrelated processes that
depend on each other to occur successfully. Our studies uncover
a crucial role of Tbx3/2 transcription factors in the regulation of
these processes and provide an entry-point for understanding the
cellular bases that underlie heart tube looping and regionalization.
MATERIALS AND METHODS
Zebrafish lines and Microinjection
Wild type zebrafish (AB) and the transgenic mlc2a::GFP line [30]
wereusedinthisstudy.pCS2+ vectorscarryingcDNAinsertscoding
for mouse Tbx3, human TBX2 and green fluorescent protein (GFP)
were synthesized using the SP6 mMessage Machine System
according to the manufacturer’s instructions (Ambion). Capped
mRNAs and morpholino oligonucleotides (MO) were injected into
one-cell stage embryos as described [49]. MOs were designed to
specifically inhibit RNA translation of the targeted gene and were





Injection of the same amount of control MO did not produce
any detectable defects.
Cloning of zebrafish tbx3b, tbx2a, and bmp10 genes
A zebrafish embryonic cDNA library was screened with low
stringency hybridization using the T-box domain of zebrafish tbx5
as a probe. 59RACE-PCR was performed to obtain the open
reading frame sequence for tbx3b and tbx2a. The sequences were
submitted to NCBI molecular database. The zebrafish cDNA
ensembl database (Zv5) was blasted with the cDNA sequence from
mouse and human Bmp10. We obtained one cDNA sequence with
significant similarity, which was amplified by RT-PCR. By
comparing the expression pattern of this gene with the one from
mouse Bmp10 we concluded that it is zebrafish bmp10.
Whole Mount in situ Hybridization
Whole-mount in situ hybridization for zebrafish embryos was
performed as described [49]. The zebrafish antisense RNA probes
for nkx2.5, anf, bmp2a, bmp2b and has2 were obtained by RT-PCR
of a cDNA fragment including the 39 UTR, bmp4, tbx5 and versican
were previously described [49,51] and hrT was kindly provided by
D.Yelon. For mouse embryos, in situ hybridization was performed
as described [49]. The mouse antisense probes for Bmp10, Anf,
Smad6, and TGFb2 were obtained by RT-PCR of a cDNA
fragment including 39 UTR.
Analysis of cell proliferation
To analyze cell proliferation in the zebrafish heart, aprox. 2 nl of
1 mg/ml bromodeoxyuridine (BrdU) was injected in the pericar-
diac cavity of tricaine anesthetized embryos, which were fixed after
one hour. The distribution of BrdU-positive cells along the
progressive zone of the 48hpf fin bud confirmed that this approach
is reliable (data not shown) [49]. Whole-mount immunofluores-
cence was performed using standard protocols using anti-BrdU
antibody conjugated to fluorescein (Roche). BrdU-injected em-
bryos were then stripped of their head, oriented in solidifying 0.5%
agarose and photographed using a BioRad confocal microscope.
To analyze cell proliferation in the mouse heart, pregnant female
mice were IP injected with BrdU solution at 100 mg/g body
weight. Embryos were recovered after 1 h, fixed and embedded in
paraffin. Ten-micrometer serial sections were cut and processed
for staining. Epitopes were recovered by boiling the slides for
20 minutes in unmasking solution (VectorLabs). Mice immuno-
histochemistry was performed according to standard protocols.
The antibodies used were MF20, 1:100, obtained from the
Developmental Studies Hybridoma Bank, anti-BrdU conjugated
to fluorescein, 1:100 (Roche), anti-BrdU, 1:200 (Accurate
Chemical) and anti-phospho Histone3, 1:300 (Ser10; Upstate).
Generation of Tbx3 KO mice
Targeted disruption of the mouse Tbx3 locus to produce the
Tbx3neo allele by homologous recombination in embryonic stem
(ES) cells was performed. Details of the targeting strategy and
other analyses are shown in Supplemental Figure S4 and
Supplemental Methods S1. In brief, a loxP-flanked neo selection
cassette was inserted into the first exon of the Tbx3 locus by
homologous recombination in J1 ES cells. This neo cassette
contains multiple stop codons that prevent translation of Tbx3
mRNA into protein, thus we considered this generated allele as
a null mutated allele, and called it Tbx3neo. Germ-line chimeras
were generated by injection of targeted ES cells into C57BL/6
host blastocysts. Chimeras were mated with 129t females and the
first progeny were confirmed to harbor the Tbx3neo allele by
Southern analysis and PCR.
SUPPORTING INFORMATION
Figure S1 Zebrafis tbx3b and tbx2a are orthologues of mouse
Tbx3 and Tbx2. Dorsal (A, C) and lateral views (B, D) of in situ
hybridized 48 hpf embryos with tbx3b (A, B) and tbx2a (C, D).
Asterisk indicates the fin bud. (E) Comparison of the amino acid
sequence of the T-box domain of several Tbx2 subfamily proteins
shows that tbx3b and tbx2a exhibit high similarity with other
members from this family.
Found at: doi:10.1371/journal.pone.0000398.s001 (3.00 MB TIF)
Figure S2 tbx3b and tbx2a efficiently prevent translation of their
target messenger RNAs. (A–D) epiboly stage. Capped RNA
encoding for tbx3b:EGFP or tbx2a:EGFP fusion proteins was
injected with or without the respective MO to verify the efficiency
of MOs to abolish translation of tbx3b and tbx2a mRNAs. In the
presence of the MO, no fluorescent signal was present indicating
that translation of the fusion constructs was abolished.
Found at: doi:10.1371/journal.pone.0000398.s002 (1.74 MB TIF)
Figure S3 Expression pattern of zebrafish bmp10. Whole mount
in situ hybridization of embryos at 24 hpf (A, B) and 60 hpf.(C, D).
(A) dorsal view of the head; (B) lateral view; (C) lateral and dorsal
view of the head and (D) ventral view of the heart. (A, B) Zebrafish
bmp10 is expressed in the brain and the whole heart tube at
24 hpf. (C, D) At 60 hpf, bmp 10 is expressed in the myocardium
of the heart chambers as well as in the otic vesicle. a, atrium; h,
heart; op, otic vesicle; v, ventricle.
Found at: doi:10.1371/journal.pone.0000398.s003 (3.24 MB TIF)
Figure S4 Targeting strategy to produce the Tbx3 null allele. (A)
Schematic representation of genomic organization of the wild type
mouse Tbx3 locus. (B) Diagram of the targeting strategy. Target-
ing construct showing the regions of homology and the site of
insertion of the neo cassette in the Tbx3 locus. (C) Genomic
southern analysis of EcoRV digested DNA of the ES cell clones.
Found at: doi:10.1371/journal.pone.0000398.s004 (0.43 MB TIF)
Methods S1
Found at: doi:10.1371/journal.pone.0000398.s005 (0.03 MB
DOC)
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